Retour

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

News earningscall-transcripts

CMPS earnings call for the period ending March 31, 2024.

The Motley Fool • 09/05/2024 à 10:45:11
COMPASS Pathways Plc American Depository Shares
Address: 3RD FLOOR, 1 ASHLEY ROAD
Postal Code: WA14 2DT
City: CHESIRE
State: X0
Phone Number: 1-716-676-6461
Website: https://www.compasspathways.com
Status: Active
Company Info

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

List Date2020-09-18
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeADRC
Currency NameUSD
CIK0001816590
Composite figiBBG00X0VY2N1
Share Class figiBBG00X0VY3F8
Market Cap536,105,919 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees186
Share Class Shares Outstanding68380000
Weighted Shares Outstanding68380857
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
7.99
8.21
8.28
8.13
8.175
Variance
-2.7%
-0.63%
1.35%
-0.62%
1.46%
Open
8.212
8.262
8.17
8.181
8.057
Highest
8.22
8.375
8.435
8.447
8.2
Lowest
8.22
8.375
8.388
8.416
8.2
History
PeriodVarhighestlowest
1 week
-0.83%
8.2
8.2
1 month
-6.57%
8.885
8.071
3 month
-28.55%
11.297
8.071
6 month
33.61%
6.2
5.486
1 year
-0.87%
8.25
5.01
3 year
-76.91%
36.52
5.01
5 year
-65.85%
29.01
5.01
10 year
-65.85%
29.01
5.01
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-03 2023-11-02 UNPUB
Assets 173,310,000 209,834,000 299,033,000 UNPUB
Current Assets 167,826,000 193,601,000 284,806,000 UNPUB
Current Liabilities 11,254,000 12,775,000 15,350,000 UNPUB
Equity 161,644,000 166,396,000 253,255,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 161,644,000 166,396,000 253,255,000 UNPUB
Liabilities 11,666,000 43,438,000 45,778,000 UNPUB
Liabilities And Equity 173,310,000 209,834,000 299,033,000 UNPUB
Noncurrent Assets 5,484,000 16,233,000 14,227,000 UNPUB
Noncurrent Liabilities 412,000 30,663,000 30,428,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-03 2023-11-02 UNPUB
Exchange Gains/Losses 666,000 12,000 179,000 UNPUB
Net Cash Flow -26,007,000 31,111,000 99,884,000 UNPUB
Net Cash Flow, Continuing -26,673,000 31,099,000 99,705,000 UNPUB
Net Cash Flow From Financing Activities 1,079,000 55,929,000 116,781,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 1,079,000 55,929,000 116,781,000 UNPUB
Net Cash Flow From Investing Activities -29,000 -17,000 -18,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -29,000 -17,000 -18,000 UNPUB
Net Cash Flow From Operating Activities -27,723,000 -24,813,000 -17,058,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -27,723,000 -24,813,000 -17,058,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-03 2023-11-02 UNPUB
Comprehensive Income/Loss -24,786,000 -27,618,000 -34,127,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -24,786,000 -27,618,000 -34,127,000 UNPUB
Other Comprehensive Income/Loss -24,786,000 -27,618,000 -34,127,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-03 2023-11-02 UNPUB
Basic Earnings Per Share -1 -1 -1 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share -1 -1 -1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -24,208,000 -28,335,000 -33,389,000 UNPUB
Income/Loss From Continuing Operations Before Tax -24,078,000 -28,141,000 -33,327,000 UNPUB
Income Tax Expense/Benefit 130,000 194,000 62,000 UNPUB
Interest Expense, Operating UNPUB UNPUB 1,080,000 UNPUB
Net Income/Loss -24,208,000 -28,335,000 -33,389,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -24,208,000 -28,335,000 -33,389,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -24,208,000 -28,335,000 -33,389,000 UNPUB
Operating Expenses 31,788,000 32,664,000 34,062,000 UNPUB
Operating Income/Loss -31,788,000 -32,664,000 -34,062,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 0 0 0 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-03 2023-02-28
Assets 272,097,000 238,636,000 224,520,000 197,294,000
Current Assets 266,552,000 231,994,000 218,451,000 191,651,000
Current Liabilities 11,680,000 13,233,000 29,533,000 15,596,000
Equity 259,574,000 224,585,000 194,562,000 181,280,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 259,574,000 224,585,000 194,562,000 181,280,000
Liabilities 12,523,000 14,051,000 29,958,000 16,014,000
Liabilities And Equity 272,097,000 238,636,000 224,520,000 197,294,000
Noncurrent Assets 5,545,000 6,642,000 6,069,000 5,643,000
Noncurrent Liabilities 0 0 425,000 418,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-03 2023-02-28
Exchange Gains/Losses -6,543,000 -18,303,000 -15,033,000 -24,959,000
Net Cash Flow -29,559,000 -36,507,000 -34,050,000 -129,966,000
Net Cash Flow, Continuing -23,016,000 -18,204,000 -19,017,000 -105,007,000
Net Cash Flow From Financing Activities 189,000 213,000 -1,000 1,040,000
Net Cash Flow From Financing Activities, Continuing 189,000 213,000 -1,000 1,040,000
Net Cash Flow From Investing Activities -82,000 -412,000 5,000 -596,000
Net Cash Flow From Investing Activities, Continuing -82,000 -412,000 5,000 -596,000
Net Cash Flow From Operating Activities -23,123,000 -18,005,000 -19,021,000 -105,451,000
Net Cash Flow From Operating Activities, Continuing -23,123,000 -18,005,000 -19,021,000 -105,451,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-03 2023-02-28
Comprehensive Income/Loss -21,171,000 -21,037,000 -33,527,000 -117,212,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -28,364,000 -38,171,000 -33,527,000 -117,212,000
Other Comprehensive Income/Loss 0 0 -33,527,000 -117,212,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-03 2023-02-28
Basic Earnings Per Share -1 -1 0 -2
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share -1 -1 0 -2
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -21,171,000 -21,037,000 -18,371,000 -91,505,000
Income/Loss From Continuing Operations Before Tax -21,031,000 -20,981,000 -18,251,000 -91,097,000
Income Tax Expense/Benefit 140,000 56,000 120,000 408,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -21,171,000 -21,037,000 -18,371,000 -91,505,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,171,000 -21,037,000 -18,371,000 -91,505,000
Net Income/Loss Available To Common Stockholders, Basic -21,171,000 -21,037,000 -18,371,000 -91,505,000
Operating Expenses 25,420,000 27,256,000 25,536,000 110,403,000
Operating Income/Loss -25,420,000 -27,256,000 -25,536,000 -110,403,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2022-02-24
Assets UNPUB UNPUB UNPUB 300,898,000
Current Assets UNPUB UNPUB UNPUB 295,300,000
Current Liabilities UNPUB UNPUB UNPUB 15,107,000
Equity UNPUB UNPUB UNPUB 284,412,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 284,412,000
Liabilities UNPUB UNPUB UNPUB 16,486,000
Liabilities And Equity UNPUB UNPUB UNPUB 300,898,000
Noncurrent Assets UNPUB UNPUB UNPUB 5,598,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 1,379,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2022-02-24
Exchange Gains/Losses UNPUB UNPUB UNPUB -5,576,000
Net Cash Flow UNPUB UNPUB UNPUB 82,991,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 88,567,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 156,646,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 156,646,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -334,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -334,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -67,745,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -67,745,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2022-02-24
Comprehensive Income/Loss UNPUB UNPUB UNPUB -77,487,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -77,487,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB -77,487,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2022-02-24
Basic Earnings Per Share UNPUB UNPUB UNPUB -2
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB -2
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -71,742,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB -71,543,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 199,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB UNPUB UNPUB -71,742,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -71,742,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -71,742,000
Operating Expenses UNPUB UNPUB UNPUB 83,221,000
Operating Income/Loss UNPUB UNPUB UNPUB -83,221,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 0
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:CMPS240517P00017500 OPASPS Put American 100 17.5 BATO 2024-05-17
O:CMPS240517P00015000 OPASPS Put American 100 15 BATO 2024-05-17
O:CMPS240517P00012500 OPASPS Put American 100 12.5 BATO 2024-05-17
O:CMPS240517P00010000 OPASPS Put American 100 10 BATO 2024-05-17
O:CMPS240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:CMPS240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:CMPS240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:CMPS240517C00017500 OCASPS Call American 100 17.5 BATO 2024-05-17
O:CMPS240517C00015000 OCASPS Call American 100 15 BATO 2024-05-17
O:CMPS240517C00012500 OCASPS Call American 100 12.5 BATO 2024-05-17
O:CMPS240517C00010000 OCASPS Call American 100 10 BATO 2024-05-17
O:CMPS240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:CMPS240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:CMPS240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:CMPS240517P00022500 OPASPS Put American 100 22.5 BATO 2024-05-17
O:CMPS240517P00020000 OPASPS Put American 100 20 BATO 2024-05-17
O:CMPS240517C00022500 OCASPS Call American 100 22.5 BATO 2024-05-17
O:CMPS240517C00020000 OCASPS Call American 100 20 BATO 2024-05-17
O:CMPS240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:CMPS240419P00017500 OPASPS Put American 100 17.5 BATO 2024-04-19
O:CMPS240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:CMPS240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:CMPS240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:CMPS240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:CMPS240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:CMPS240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:CMPS240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:CMPS240419C00017500 OCASPS Call American 100 17.5 BATO 2024-04-19
O:CMPS240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:CMPS240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:CMPS240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:CMPS240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:CMPS240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:CMPS240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:CMPS240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:CMPS240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:CMPS240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:CMPS240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:CMPS240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:CMPS240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:CMPS240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:CMPS240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:CMPS240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:CMPS240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:CMPS240315P00017500 OPASPS Put American 100 17.5 BATO 2024-03-15
O:CMPS240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:CMPS240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:CMPS240315C00017500 OCASPS Call American 100 17.5 BATO 2024-03-15
O:CMPS240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:CMPS240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:CMPS240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:CMPS240216P00012500 OPASPS Put American 100 12.5 BATO 2024-02-16
O:CMPS240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:CMPS240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:CMPS240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:CMPS240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:CMPS240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:CMPS240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:CMPS240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:CMPS240216C00012500 OCASPS Call American 100 12.5 BATO 2024-02-16
O:CMPS240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:CMPS240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:CMPS240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:CMPS240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:CMPS240119P00070000 OPASPS Put American 100 70 BATO 2024-01-19
O:CMPS240119P00065000 OPASPS Put American 100 65 BATO 2024-01-19
O:CMPS240119P00060000 OPASPS Put American 100 60 BATO 2024-01-19
O:CMPS240119P00055000 OPASPS Put American 100 55 BATO 2024-01-19
O:CMPS240119P00050000 OPASPS Put American 100 50 BATO 2024-01-19
O:CMPS240119P00045000 OPASPS Put American 100 45 BATO 2024-01-19
O:CMPS240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:CMPS240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:CMPS240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:CMPS240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:CMPS240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:CMPS240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:CMPS240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:CMPS240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:CMPS240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:CMPS240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:CMPS240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:CMPS240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:CMPS240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:CMPS240119C00070000 OCASPS Call American 100 70 BATO 2024-01-19
O:CMPS240119C00065000 OCASPS Call American 100 65 BATO 2024-01-19
O:CMPS240119C00060000 OCASPS Call American 100 60 BATO 2024-01-19
O:CMPS240119C00055000 OCASPS Call American 100 55 BATO 2024-01-19
O:CMPS240119C00050000 OCASPS Call American 100 50 BATO 2024-01-19
O:CMPS240119C00045000 OCASPS Call American 100 45 BATO 2024-01-19
O:CMPS240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:CMPS240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:CMPS240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:CMPS240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:CMPS240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:CMPS240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:CMPS240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:CMPS240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:CMPS240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:CMPS240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:CMPS240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:CMPS240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:CMPS240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:CMPS231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:CMPS231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:CMPS231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:CMPS231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:CMPS231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:CMPS231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:CMPS231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:CMPS231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:CMPS231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:CMPS231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:CMPS231117P00020000 OPASPS Put American 100 20 BATO 2023-11-17
O:CMPS231117P00017500 OPASPS Put American 100 17.5 BATO 2023-11-17
O:CMPS231117P00015000 OPASPS Put American 100 15 BATO 2023-11-17
O:CMPS231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:CMPS231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:CMPS231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:CMPS231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:CMPS231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:CMPS231117C00020000 OCASPS Call American 100 20 BATO 2023-11-17
O:CMPS231117C00017500 OCASPS Call American 100 17.5 BATO 2023-11-17
O:CMPS231117C00015000 OCASPS Call American 100 15 BATO 2023-11-17
O:CMPS231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:CMPS231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:CMPS231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:CMPS231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:CMPS231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:CMPS231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:CMPS231020P00012500 OPASPS Put American 100 12.5 BATO 2023-10-20
O:CMPS231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:CMPS231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:CMPS231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:CMPS231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:CMPS231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:CMPS231020C00012500 OCASPS Call American 100 12.5 BATO 2023-10-20
O:CMPS231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:CMPS231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:CMPS231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:CMPS231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:CMPS230915P00017500 OPASPS Put American 100 17.5 BATO 2023-09-15
O:CMPS230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:CMPS230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:CMPS230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:CMPS230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:CMPS230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:CMPS230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:CMPS230915C00017500 OCASPS Call American 100 17.5 BATO 2023-09-15
O:CMPS230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:CMPS230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:CMPS230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:CMPS230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:CMPS230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:CMPS230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:CMPS230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:CMPS230818P00017500 OPASPS Put American 100 17.5 BATO 2023-08-18
O:CMPS230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:CMPS230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:CMPS230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:CMPS230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:CMPS230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:CMPS230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:CMPS230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
O:CMPS230818C00017500 OCASPS Call American 100 17.5 BATO 2023-08-18
O:CMPS230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:CMPS230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:CMPS230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:CMPS230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:CMPS230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:CMPS230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
News earningscall-transcripts
Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript
CMPS earnings call for the period ending March 31, 2024.
The Motley Fool • 1w ago
Stocks Earnings Releases and Operating Results
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2024 and provided an update on recent business progress.
GlobeNewswire Inc. • 1w ago
Health Health
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today announced top-line results from an open-label phase 2 study evaluating the safety and tolerability of investigational COMP360 psilocybin treatment in 22 patients with post-traumatic stress disorder (PTSD). The study met its primary safety endpoint and available secondary efficacy endpoints. Study observations included meaningful and sustained symptom improvement from baseline in mean CAPS-5 total score, a measure of disease severity, and in Sheehan Disability Scale (SDS) score, a measure of functional impairment in daily life. Administration of COMP360 was well-tolerated, with a safety profile consistent with previous studies.
GlobeNewswire Inc. • 1w ago
Health Health
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Mindful Health Solutions (MHS), one of the US’s leading providers of innovative behavioral health care, today announced that they have entered into a research collaboration agreement to inform the development of a scalable and cost-effective delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression (TRD). This is the latest of several collaborations for Compass, intended to better understand a range of potential approaches to deliver COMP360 to patients in different care settings.
GlobeNewswire Inc. • 2w ago
Health Health
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
LONDON, April 29, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Journey Clinical, a leading psychedelic-assisted psychotherapy platform with the largest network of licensed therapists focused on psychedelics in the US, today announced they have entered into a research collaboration agreement to inform the development of a scalable and practical delivery and healthcare provider training model for COMP360 psilocybin treatment, if approved for treatment-resistant depression (TRD).
GlobeNewswire Inc. • 2w ago
Health Health
Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd Annual Needham Virtual Healthcare Conference at 8:00am ET on April 9, 2024.
GlobeNewswire Inc. • 1mo ago
Management Management statements
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New Chair David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New Chair
GlobeNewswire Inc. • 1mo ago
News earningscall-transcripts
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript
CMPS earnings call for the period ending December 31, 2023.
The Motley Fool • 2mo ago
Stocks Earnings Releases and Operating Results
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights 
LONDON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the fourth quarter 2023 and provided an update on recent progress across its business.
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Compass Pathways to participate in upcoming TD Cowen investor conference
LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference at 12:50 pm ET on March 4, 2024.
GlobeNewswire Inc. • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT